 China Pharma Holdings, Inc. NYSE American: CPHI China Pharma, the Company or We, an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in China, today announced that it is re-issuing its previous release that was made on March 31, 2020 to incorporate certain disclosures that are required under the NYSE American Company Guide Sections 401h and 610b. Included below are these additional disclosures along with the previously disclosed financial results for the fiscal year ended December 31, 2019. 